Ignite Creation Date:
2024-05-06 @ 5:19 PM
Last Modification Date:
2024-10-26 @ 2:26 PM
Study NCT ID:
NCT05261646
Status:
WITHDRAWN
Last Update Posted:
2023-09-28
First Post:
2022-02-21
Brief Title:
A Clinical Study of Hetrombopag Olamine Tablets in Adults Receiving 21-day Cycles of Chemotherapy for Solid Tumours Who Are Delayed for at Least 1 Week From Their Scheduled Cycle Because of Chemotherapy-induced Thrombocytopenia
Sponsor:
Jiangsu HengRui Medicine Co Ltd
Organization:
Jiangsu HengRui Medicine Co Ltd
Organization Data
Organization:
Jiangsu HengRui Medicine Co Ltd
Class:
INDUSTRY
Study ID:
HR-TPO-CIT-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Jiangsu HengRui Medicine Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None